Q3 Revenue Jumps 48% to $25.8M as ACV Plus Royalties Hit Record $103.8M
AIP sits 32% above its 52-week low of $12.06.
Summary
Arteris posted record Q3 revenue of $25.8 million, up 48% year-over-year, and ACV plus royalties of $103.8 million, up 39%. RPO rose 29% to $135.5 million, and trailing-twelve-month variable royalties jumped 71% to $9.4 million. The top line accelerated from Q2's $24.1 million, though GAAP operating loss widened to $11.3 million from $8.7 million a year ago on heavier stock-based compensation and R&D spend; the non-GAAP operating loss narrowed to $1.2 million from $3.5 million. Management guided Q4 revenue to $25.7-$26.7 million and full-year 2026 revenue to $98.5-$99.5 million, with full-year free cash flow of $5.0-$9.0 million. The quarter included major license deals with a top US hyperscaler, two leading semiconductor companies, and a major automotive OEM, plus the FlexGen Multi-Die and Ncore Multi-Die chiplet products. Cash and investments stood at roughly $120 million after the ATM program raised $72 million year-to-date.
At the time of this announcement, AIP was trading at $15.93 on NASDAQ in the Technology sector, with a market capitalization of approximately $783M. The 52-week trading range was $12.06 to $50.26. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.